108 results
Page 4 of 6
8-K
EX-99.1
c548392im peh
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
vv0z 47xt8e
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
ud7l7 hv50to
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.2
69tzdcdu7kl05y43
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
yxz9sz2 y22
20 May 19
Other Events
8:52am
8-K
EX-99.1
9zfp8oypy2rg0
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
an5zpsx4f78r
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
h8k3e riex
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
f3k38ar
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.2
thl86gp 49t3
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
ney3tpry p3
7 Jan 19
Other Events
7:01am
8-K
EX-99.1
vfbwaoa9
10 Dec 18
Other Events
2:07pm
8-K
EX-99.2
upkj0qk
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
n9om35 2x
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
y3ko0v1b
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am